Literature DB >> 12646783

Acute inflammatory events and ischemic stroke subtypes.

Patrizia Nencini1, Cristina Sarti, Rinaldo Innocenti, Giovanni Pracucci, Domenico Inzitari.   

Abstract

BACKGROUND: Recent studies have suggested that previous infection may be a risk factor for ischemic stroke mainly in young and middle-aged patients. The present study sought to further investigate the association between recent inflammatory events (IE) and ischemic stroke without age restriction and to determine the role of recent IE in different ischemic stroke subtypes.
METHODS: We performed a case-control study with 93 consecutive hospitalized stroke patients and 200 (107 hospital and 93 community) controls. Acute IE, both infective and non-infective, occurring in the previous 30 days were assessed using a standard questionnaire. The TOAST criteria were used for ischemic stroke subtypes classification.
RESULTS: Acute IE in the previous 30 and 7 days were significantly and independently associated with ischemic stroke (37/93 vs. 47/200; OR 2.23, 95% CI 1.26-3.96 and 17/93 vs.16/200; OR 2.45, 95% IC 1.11-5.39, respectively). Stratifying for stroke subtypes, acute IE significantly and independently increased the risk of atherothrombotic (OR 5.72, 95% CI 2.14-15.25) and cardioembolic stroke (OR 3.02, 95%CI 1.20-7.63).
CONCLUSIONS: Acute IE increase the risk of acute ischemic stroke of atherothrombotic and cardioembolic type independently of other predisposing factors. Implications for daily clinical practice, in relation to prevention and treatment of IE in patients at risk, have to be explored. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2003        PMID: 12646783     DOI: 10.1159/000068831

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  10 in total

Review 1.  Common infections and the risk of stroke.

Authors:  Armin J Grau; Christian Urbanek; Frederick Palm
Journal:  Nat Rev Neurol       Date:  2010-11-09       Impact factor: 42.937

2.  Inflammation is detrimental for neurogenesis in adult brain.

Authors:  Christine T Ekdahl; Jan-Hendrik Claasen; Sara Bonde; Zaal Kokaia; Olle Lindvall
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-27       Impact factor: 11.205

3.  Regulation of injury-induced neurogenesis by nitric oxide.

Authors:  Bruno P Carreira; Caetana M Carvalho; Inês M Araújo
Journal:  Stem Cells Int       Date:  2012-09-10       Impact factor: 5.443

4.  Infections and ischemic stroke outcome.

Authors:  Katarzyna Grabska; Grażyna Gromadzka; Anna Członkowska
Journal:  Neurol Res Int       Date:  2011-06-28

5.  Stroke caused by an inflammatory thrombus: a case report.

Authors:  Kai Shan; Wei Guo
Journal:  BMC Neurol       Date:  2017-02-16       Impact factor: 2.474

Review 6.  Herpes zoster and the risk of ischemic and hemorrhagic stroke: A systematic review and meta-analysis.

Authors:  Ying Lian; Yun Zhu; Fang Tang; Bing Yang; Ruisheng Duan
Journal:  PLoS One       Date:  2017-02-08       Impact factor: 3.240

7.  Stem-Cell-Derived Circulating Progenitors Dysfunction in Behçet's Syndrome Patients Correlates With Oxidative Stress.

Authors:  Giacomo Emmi; Amanda Mannucci; Flavia Rita Argento; Elena Silvestri; Augusto Vaglio; Alessandra Bettiol; Alessandra Fanelli; Laura Stefani; Niccolò Taddei; Domenico Prisco; Claudia Fiorillo; Matteo Becatti
Journal:  Front Immunol       Date:  2019-12-13       Impact factor: 7.561

8.  Ginsenoside Rg1 Inhibits Microglia Pyroptosis Induced by Lipopolysaccharide Through Regulating STAT3 Signaling.

Authors:  Yueyi Yao; Changyan Li; Fusheng Qian; Yu Zhao; Xiaoyi Shi; Dan Hong; Qinglong Ai; Lianmei Zhong
Journal:  J Inflamm Res       Date:  2021-12-07

Review 9.  Adult neurogenesis, neuroinflammation and therapeutic potential of adult neural stem cells.

Authors:  Philippe Taupin
Journal:  Int J Med Sci       Date:  2008-06-05       Impact factor: 3.738

Review 10.  Infectious agents and age-related neurodegenerative disorders.

Authors:  Mark P Mattson
Journal:  Ageing Res Rev       Date:  2004-01       Impact factor: 10.895

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.